SEC Form 4 · accession 0001562180-15-001020
Dermira, Inc. · DERM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugene A Bauer
Officer — Chief Medical Officer · Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 2, 2015 · 3:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Dec 1, 2015 | S | 1,379 | $29.07 | D | 75,599 | I | By the Bauer Family 1995 Trust |
| Common StockF4,F3 | Dec 1, 2015 | S | 921 | $30.29 | D | 74,678 | I | By the Bauer Family 1995 Trust |
| Common StockF6,F3 | Dec 1, 2015 | S | 200 | $30.70 | D | 74,478 | I | By the Bauer Family 1995 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These trades were made pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $28.42 to $29.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The Reporting Person is a Co-Trustee.
- F4This transaction was executed in multiple trades at prices ranging from $29.57 to $30.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5These trades were made pursuant to a Rule 10b5-1 trading plan.
- F6This transaction was executed in multiple trades at prices ranging from $30.60 to $30.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.